Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetics and Molecular Pathology, |
RCV003447484 | SCV004175618 | likely pathogenic | Hereditary factor XI deficiency disease | 2022-12-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004782040 | SCV005394187 | uncertain significance | not specified | 2024-09-27 | criteria provided, single submitter | clinical testing | Variant summary: F11 c.152C>T (p.Thr51Ile) results in a non-conservative amino acid change located in the Apple domain (IPR000177) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251466 control chromosomes (gnomAD). c.152C>T has been reported in the literature in individuals affected with Hereditary factor XI deficiency disease (Fard-Esfahani_2008, Bicocchi_2013, Kaya_2022). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 18005151, 33560085, 23305485). ClinVar contains an entry for this variant (Variation ID: 68181). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
Uni |
RCV000059013 | SCV000090534 | not provided | not provided | no assertion provided | not provided |